Interferon-mediated signaling (WP4558)

Homo sapiens

Interferons (IFNs) can be devided in three classes, Type I, II and III. Type I IFNs are created when the cell surface or specific receptors recognize microbial products; these are structural homologues of one another which bind the same receptor. Binding to this receptor leads to an activation of kinases which regulate the phosphorylation and therefore activation of some STAT proteins (see PW for details). There is only 1 Type II interferon, INF-gamma, consisting of two subunits (R1 and R2), which associate with Jak 1 and 2, respectively. Activation of Jak1 and Jak2 leads to phosphorylation of STAT1, which ultimately binds to IFN-gamma-activated sequence (GAS) elements, regulating the transcription of genes. Type III interferons are considered a protein family of 4, which bind to a different receptor compared to Type I interferons, however they trigger the same STAT1+2 phosphorylation reactions as TypeI IFNs.

Authors

Paul Rgnier , Andra Waagmeester , Denise Slenter , Kristina Hanspers , and Eric Weitz

Activity

last edited

Discuss this pathway

Check for ongoing discussions or start your own.

Cited In

Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.

Organisms

Homo sapiens

Communities

Annotations

Pathway Ontology

type II interferon signaling pathway signaling pathway type I interferon signaling pathway

Participants

Label Type Compact URI Comment
JAK1 GeneProduct ncbigene:3716
TYK2 GeneProduct ncbigene:7297
JAK2 GeneProduct ncbigene:3717
STAT1 GeneProduct ncbigene:6772
STAT2 GeneProduct ncbigene:6773
PIK3R1 GeneProduct ncbigene:5295
PIK3CA GeneProduct ncbigene:5290
PRKCA GeneProduct ncbigene:5578
IRF9 GeneProduct ncbigene:10379
IFNAR2 GeneProduct ncbigene:3455
IFNAR1 GeneProduct ncbigene:3454
IFNGR1 GeneProduct ncbigene:3459
IFNGR2 GeneProduct ncbigene:3460
IFNA1 GeneProduct ncbigene:3439
IFNA7 GeneProduct ncbigene:3444
IFNG GeneProduct ncbigene:3458
IFNLR1 GeneProduct ncbigene:163702
IL10RB GeneProduct ncbigene:3588
IFNL1 GeneProduct ncbigene:282618
IFNL2 GeneProduct ncbigene:282616
IFNL3 GeneProduct ncbigene:282617
IFNL4 GeneProduct ncbigene:101180976
IFNA5 GeneProduct ncbigene:3442
IFNA6 GeneProduct ncbigene:3443
IFNA4 GeneProduct ncbigene:3441
IFNA2 GeneProduct ncbigene:3440
IFNA8 GeneProduct ncbigene:3445
IFNA10 GeneProduct ncbigene:3446
IFNA13 GeneProduct ncbigene:3447
IFNA14 GeneProduct ncbigene:3448
IFNA16 GeneProduct ncbigene:3449
IFNA17 GeneProduct ncbigene:3451
IFNA21 GeneProduct ncbigene:3452
IFNB1 GeneProduct ncbigene:3456
IFNE GeneProduct ncbigene:338376
IFNW1 GeneProduct ncbigene:3467
IFNK GeneProduct ncbigene:56832

References

  1. Mechanisms of type-I- and type-II-interferon-mediated signalling. Platanias LC. Nat Rev Immunol. 2005 May;5(5):375–86. PubMed Europe PMC Scholia
  2. Direct effects of type I interferons on cells of the immune system. Hervas-Stubbs S, Perez-Gracia JL, Rouzaut A, Sanmamed MF, Le Bon A, Melero I. Clin Cancer Res. 2011 May 1;17(9):2619–27. PubMed Europe PMC Scholia
  3. Decoding type I and III interferon signalling during viral infection. Mesev EV, LeDesma RA, Ploss A. Nat Microbiol. 2019 Jun;4(6):914–24. PubMed Europe PMC Scholia